Main content

    Dystonia Clinical Trials

    Sutter Health participates in clinical trials related to Dystonia throughout their Northern California facilities. See the listing below for an overview of current trials, including contact information. For some trials, more detailed information can be found via the title link to ClinicalTrials.gov.

    Title: ASPIRE: Adult Spasticity International Registry on BOTOX Treatment.Opens in a new window external site
    Decscription: This study will determine patterns of utilization of BOTOX for the treatment of spacticity, including but not limited to characteristics of enrolling and treating health care providers, and practices, measured by satisfaction and safety. This study will not provide or recommend any treatment.
    Investigator: Nicklesh Thakue, DO
    Eligibility: Patients 18 and over clinical diagnosed with cervical dystonia that have recently been treated with BOTOX injections.
    Status: Active and open to enrollment
    Location: Sutter Medical Group
    Contact: Cammy Rieger, CRC, 916-453-5740
    Email: riegerc@sutterhealth.org

    Title: DYSPORT for Injection AbobotulinumtoxinA Neurotoxin Clinical and Health Economics Outcomes Registry in Cervical Dystonia (ANCHOR-CD) (Tercica, Inc)
    Decscription: The purpose of the protocol is to determine typical patient response to Dysport in the treatment of adult cervical dystonia (CD).
    Investigator: Matthew Arnold, MD
    Eligibility: Patients with Cervical Dystonia/Spasmodic Torticollis.
    Status: Active and open to enrollment
    Location: Alta Bates Summit Medical Center
    Contact: Jody Dosanjh 510-204-1610 Email: dosanjp@sutterhealth.org

    > See All Neurology Clinical Trials by Condition